Literature DB >> 19330595

Hypogonadism on admission to acute rehabilitation is correlated with lower functional status at admission and discharge.

N E Carlson1, L A Brenner, M E Wierman, C Harrison-Felix, C Morey, S Gallagher, D Ripley.   

Abstract

PRIMARY
OBJECTIVE: To investigate the association between hormone levels and functional status during acute TBI rehabilitation. RESEARCH
DESIGN: Retrospective cohort study of 43 men with moderate-to-severe TBI admitted to an acute rehabilitation unit during a 1 year period. METHODS AND PROCEDURES: Labs were drawn on admission, including total and free testosterone (T), prolactin, adrenocorticotropin hormone (ACTH), cortisol, thyroid stimulating hormone (TSH), free thyroxine (fT4) and insulin-like growth factor (IGF-1). Functional Independence Measure (FIM) scores were obtained at admission and discharge. MAIN OUTCOME AND
RESULTS: Associations between admission hormone levels and the main outcomes, admission and discharge FIM scores, were assessed using linear regression. Lower total and free T-levels at admission were associated with lower total FIM scores at admission (p < 0.038) and discharge (p < 0.046). Higher cortisol levels at admission were significantly associated with lower admission (p = 0.012) and discharge (p = 0.036) scores on the cognitive-FIM. Prolactin, TSH, fT4 and IGF-1 were not correlated with functional status.
CONCLUSIONS: In men, lower total and free T-levels at admission to acute rehabilitation correlate with lower admission and discharge FIM scores. These data support the need for studies to investigate the impact of physiological testosterone therapy on outcomes during and post-rehabilitation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330595     DOI: 10.1080/02699050902788535

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  6 in total

1.  Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know.

Authors:  Raeesa Gupte; William Brooks; Rachel Vukas; Janet Pierce; Janna Harris
Journal:  J Neurotrauma       Date:  2019-07-19       Impact factor: 5.269

2.  Persistent Hypogonadotropic Hypogonadism in Men After Severe Traumatic Brain Injury: Temporal Hormone Profiles and Outcome Prediction.

Authors:  David J Barton; Raj G Kumar; Emily H McCullough; Gary Galang; Patricia M Arenth; Sarah L Berga; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2016 Jul-Aug       Impact factor: 2.710

3.  Anti-Pituitary and Anti-Hypothalamus Autoantibody Associations with Inflammation and Persistent Hypogonadotropic Hypogonadism in Men with Traumatic Brain Injury.

Authors:  Sushupta M Vijapur; Zhihui Yang; David J Barton; Leah Vaughan; Nabil Awan; Raj G Kumar; Byung-Mo Oh; Sarah L Berga; Kevin K Wang; Amy K Wagner
Journal:  J Neurotrauma       Date:  2020-04-13       Impact factor: 5.269

4.  Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact Injury.

Authors:  Rastafa I Geddes; Kentaro Hayashi; Quinn Bongers; Marlyse Wehber; Icelle M Anderson; Alex D Jansen; Chase Nier; Emily Fares; Gabrielle Farquhar; Amita Kapoor; Toni E Ziegler; Sivan VadakkadathMeethal; Ian M Bird; Craig S Atwood
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

5.  Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury.

Authors:  Lisa A Kreber; Grace S Griesbach; Mark J Ashley
Journal:  J Neurotrauma       Date:  2015-11-19       Impact factor: 5.269

6.  Hypogonadism induced by surgical stress and brain trauma is reversed by human chorionic gonadotropin in male rats: A potential therapy for surgical and TBI-induced hypogonadism?

Authors:  Rastafa I Geddes; Amita Kapoor; Kentaro Hayashi; Ryan Rauh; Marlyse Wehber; Quinn Bongers; Alex D Jansen; Icelle M Anderson; Gabrielle Farquhar; Sivan Vadakkadath-Meethal; Toni E Ziegler; Craig S Atwood
Journal:  Endocrinol Diabetes Metab       Date:  2021-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.